Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children" has been published. This is a nice opportunity to explain the need of patient involvement in paediatric clinical trials. https://t.co/80yrEag1Yq @c4c_network
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2022 – Jun 2023Where it's discussed
-
X / Twitter13 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions demonstrate a strong positive perception of the article, with comments like 'A must read' and highlighting the opportunity to explain the need for patient involvement, indicating high interest and moderate engagement. The tone suggests that stakeholders see the publication as an important step forward in pediatric drug development, emphasizing its relevance and potential impact in the field.
Most discussions express support and positive views about the publication, emphasizing the importance of expert advice and patient involvement.
The posts show high interest, with multiple mentions of the publication, its significance, and calls to learn more, reflecting engagement and curiosity.
Participants refer to specific aspects like the role of patient involvement and the structure of pediatric trials, indicating moderate to deep engagement.
The discussions highlight the publication’s potential to influence pediatric trial design and stakeholder practices, albeit more as a shared interest than immediate change.
Abstract in brief
- The c4c project is an initiative aimed at improving pediatric drug development by creating a Europe-wide network of experts to support designing better clinical trials for children, often using off-label medicines.
- The project involves a structured process where sponsors seek advice through interviews and expert meetings, receiving tailored recommendations that incorporate patient and family input, which enhances trial feasibility and innovation.
- As of September 2022, c4c successfully handled multiple advice requests, demonstrating that its multidisciplinary, expert-driven approach is effective and well-received by both sponsors and patient representatives in developing pediatric medicines.]
Top posts
Most liked on X and BlueskyA must read: the recently published paper by @CTSJournal regarding ‘’Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children’’. Sounds interesting? Learn more https://t.co/mHcVj6xl1S @ASCPTJournals
RT @c4c_network: A must read: the recently published paper by @CTSJournal regarding ‘’Clinical, methodology, and patient/carer expert advic…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
Open Access UCL Research: Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children https://t.co/3GwXa7r6am
All mentions
Optimizing Pediatric Drug Development with Clinical and Patient Expert Advice
This video discusses the c4c initiative's approach to improving pediatric drug development by creating a Europe-wide network of experts to support clinical trial design, incorporating patient and family input for better…
Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children #c4cExpertGroupLeads https://t.co/CXFd7bZz1L
RT @c4c_network: A must read: the recently published paper by @CTSJournal regarding ‘’Clinical, methodology, and patient/carer expert advic…
RT @c4c_network: A must read: the recently published paper by @CTSJournal regarding ‘’Clinical, methodology, and patient/carer expert advic…
RT @c4c_network: A must read: the recently published paper by @CTSJournal regarding ‘’Clinical, methodology, and patient/carer expert advic…
A must read: the recently published paper by @CTSJournal regarding ‘’Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children’’. Sounds interesting? Learn more https://t.co/mHcVj6xl1S @ASCPTJournals
Open Access UCL Research: Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children https://t.co/3GwXa7r6am
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
RT @BegonyaNafria: Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children…
Today our paper "Clinical, methodology, and patient/carer expert advice in pediatric drug development by conect4children" has been published. This is a nice opportunity to explain the need of patient involvement in paediatric clinical trials. https://t.co/80yrEag1Yq @c4c_network
BN
CC
E
LB
SW
UD
JK
LH
M
PU
BR
DL
JW